• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经会阴模板引导靶向活检与徒手经会阴活检在中国PSA<20 ng/ml患者中的比较:癌症检出率相似但病灶检出率不同

Trans-Perineal Template-Guided Mapping Biopsy vs. Freehand Trans-Perineal Biopsy in Chinese Patients With PSA < 20 ng/ml: Similar Cancer Detection Rate but Different Lesion Detection Rate.

作者信息

He Bi-Ming, Chen Rui, Shi Zhen-Kai, Xiao Guang-An, Li Hu-Sheng, Lin Heng-Zhi, Ji Jin, Peng Hong-Xiang, Wang Yan, Sun Ying-Hao, Wang Hai-Feng

机构信息

Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.

出版信息

Front Oncol. 2019 Aug 9;9:758. doi: 10.3389/fonc.2019.00758. eCollection 2019.

DOI:10.3389/fonc.2019.00758
PMID:31448239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6696794/
Abstract

The present study aimed to investigate the diagnostic efficacy and the regional location of prostate cancer (PCa) as well as the accuracy of assessment between trans-perineal template-guided mapping biopsy (TTMB) and freehand trans-perineal biopsy (FTPB) for men with PSA < 20 ng/ml. Thus, we evaluated 623 consecutive patients with PSA < 20 ng/ml who had prostate biopsies in our institute between July 2017 and September 2018. Patients were divided into two groups based on different biopsy methods: 217 (34.83%) patients with TTMB and 406 (65.17%) with FTPB. Thirty six patients with TTMB and 80 with FTPB had continued undergone radical prostatectomy after a cancer diagnosis. Then the Gleason score of the biopsy and the post-radical prostatectomy specimens in each patient were compared. Overall, the PCa detection rate was 34.35%. There was no significant difference in PCa detection rate between TTMB and FTPB (35.48 vs. 33.74%, respectively; = 0.663). Besides, the detection rate of significant PCa (Gleason score ≥ 7) in TTMB was 29.03% while FTPB was 23.89% ( = 0.162). The detection rate at the apex of the prostate was higher than the detection rate at the base of the prostate (9.80 vs. 5.79%; < 0.01) when performing the TTMB. The FTPB would miss 10% of the positive diagnosis and almost half of the lesions. The upgraded of Gleason score from biopsy to post-radical prostatectomy was 16.67% with the TTMB and 36.25% with the FTPB ( = 0.034). The TTMB had a similar cancer detection rate, but a higher lesion detection rate and more accuracy in assess the actual Gleason score when comparing to FTPB for men with PSA < 20 ng/ml. By performing a 20-core TTMB, the cancer detection rate at the apex of the prostate was higher than the base.

摘要

本研究旨在调查前列腺癌(PCa)的诊断效能、区域定位,以及经会阴模板引导穿刺活检(TTMB)和徒手经会阴穿刺活检(FTPB)对PSA<20 ng/ml男性患者的评估准确性。因此,我们评估了2017年7月至2018年9月期间在我院进行前列腺活检的623例连续PSA<20 ng/ml的患者。根据不同的活检方法将患者分为两组:217例(34.83%)接受TTMB的患者和406例(65.17%)接受FTPB的患者。36例接受TTMB的患者和80例接受FTPB的患者在癌症诊断后继续接受了根治性前列腺切除术。然后比较了每位患者活检标本和根治性前列腺切除术后标本的Gleason评分。总体而言,PCa检出率为34.35%。TTMB和FTPB之间的PCa检出率无显著差异(分别为35.48%和33.74%;P = 0.663)。此外,TTMB中显著PCa(Gleason评分≥7)的检出率为29.03%,而FTPB为23.89%(P = 0.162)。进行TTMB时,前列腺尖部的检出率高于前列腺底部的检出率(9.80%对5.79%;P<0.01)。FTPB会漏诊10%的阳性诊断病例,且几乎漏诊一半的病变。从活检到根治性前列腺切除术后Gleason评分升级的比例,TTMB为16.67%,FTPB为36.25%(P = 0.034)。对于PSA<20 ng/ml的男性患者,与FTPB相比,TTMB具有相似的癌症检出率,但病变检出率更高,且在评估实际Gleason评分方面更准确。通过进行20针的TTMB,前列腺尖部的癌症检出率高于底部。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/b732110651ea/fonc-09-00758-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/a51e6eb796ff/fonc-09-00758-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/0e0f5a1fe634/fonc-09-00758-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/b732110651ea/fonc-09-00758-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/a51e6eb796ff/fonc-09-00758-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/0e0f5a1fe634/fonc-09-00758-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a223/6696794/b732110651ea/fonc-09-00758-g0003.jpg

相似文献

1
Trans-Perineal Template-Guided Mapping Biopsy vs. Freehand Trans-Perineal Biopsy in Chinese Patients With PSA < 20 ng/ml: Similar Cancer Detection Rate but Different Lesion Detection Rate.经会阴模板引导靶向活检与徒手经会阴活检在中国PSA<20 ng/ml患者中的比较:癌症检出率相似但病灶检出率不同
Front Oncol. 2019 Aug 9;9:758. doi: 10.3389/fonc.2019.00758. eCollection 2019.
2
Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.对于接受主动监测且经直肠超声引导下前列腺穿刺活检结果为阴性的患者,经会阴模板引导下的靶向穿刺活检后癌症在升级及检测中的位置
Urol Int. 2019;103(3):262-269. doi: 10.1159/000501527. Epub 2019 Jul 3.
3
Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.经会阴模板引导靶向活检可识别极低风险与低风险前列腺癌之间的病理差异:对主动监测的意义
Am J Clin Oncol. 2017 Feb;40(1):53-59. doi: 10.1097/COC.0000000000000105.
4
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.活检前前列腺特异性抗原(PSA)速度不是经尿道微波热疗(TTMB)后前列腺癌诊断、Gleason评分、肿瘤位置或癌体积的可靠预测指标。
Urology. 2009 Jul;74(1):171-6. doi: 10.1016/j.urology.2008.12.013. Epub 2009 Feb 20.
5
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.肥胖与经会阴模板引导前列腺靶向穿刺活检的不良病理发现无关。
Urol Oncol. 2011 Jul-Aug;29(4):398-404. doi: 10.1016/j.urolonc.2009.08.023. Epub 2009 Nov 27.
6
Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.经会阴模板引导下的靶向活检在低风险前列腺癌治疗决策中的临床应用
Actas Urol Esp. 2016 Dec;40(10):615-620. doi: 10.1016/j.acuro.2016.05.002. Epub 2016 Aug 12.
7
Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.经直肠超声引导活检阴性后经会阴模板引导靶向活检诊断的前列腺癌的位置和分级
Am J Clin Oncol. 2018 Aug;41(8):723-729. doi: 10.1097/COC.0000000000000352.
8
Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.多参数磁共振成像与经会阴模板引导的前列腺穿刺活检相结合,以确定半消融性聚焦治疗的候选者。
BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090. Epub 2015 May 11.
9
[Complications of transperineal template-guided prostate mapping biopsy].[经会阴模板引导前列腺图谱活检的并发症]
Zhonghua Yi Xue Za Zhi. 2019 Feb 12;99(6):428-431. doi: 10.3760/cma.j.issn.0376-2491.2019.06.009.
10
A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.经会阴模板前列腺靶向活检的效用综合评估:13 年经验
Urology. 2023 Jul;177:115-121. doi: 10.1016/j.urology.2023.04.013. Epub 2023 Apr 25.

引用本文的文献

1
Detection Rates of Prostate Cancer Across Prostatic Zones Using Freehand Single-Access Transperineal Fusion Biopsies.经会阴单通道徒手融合活检对前列腺各区前列腺癌的检出率
Cancers (Basel). 2025 Jun 30;17(13):2206. doi: 10.3390/cancers17132206.
2
Shifting to transperineal prostate biopsy: A narrative review.转向经会阴前列腺活检:一项叙述性综述。
Prostate Int. 2024 Mar;12(1):10-14. doi: 10.1016/j.prnil.2023.11.003. Epub 2023 Nov 30.
3
Pooled outcomes of performing freehand transperineal prostate biopsy with the PrecisionPoint Transperineal Access System.

本文引用的文献

1
Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template.徒手经会阴前列腺活检可实现可接受的癌症检出率,并将感染风险降至最低:10区模板的经验进展
Urol Oncol. 2018 Dec;36(12):528.e15-528.e20. doi: 10.1016/j.urolonc.2018.09.013. Epub 2018 Nov 13.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
使用PrecisionPoint经会阴穿刺系统进行徒手经会阴前列腺穿刺活检的汇总结果。
BJUI Compass. 2022 Jun 28;3(6):434-442. doi: 10.1002/bco2.178. eCollection 2022 Nov.
4
Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial.高频不可逆电穿孔治疗局限性前列腺癌的扩展焦点消融:一项非随机对照试验。
JAMA Surg. 2022 Aug 1;157(8):693-700. doi: 10.1001/jamasurg.2022.2230.
5
The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3.活检密度在经会阴模板引导活检PI-RADS<3的患者中的应用
Front Oncol. 2022 Jun 8;12:918300. doi: 10.3389/fonc.2022.918300. eCollection 2022.
6
Comparison of a Personalized Prostate Biopsy Pattern With Traditional Transrectal Prostate Biopsy: Different Cancer Detection Rate.个性化前列腺活检模式与传统经直肠前列腺活检的比较:不同的癌症检出率。
Front Cell Dev Biol. 2022 May 4;10:851359. doi: 10.3389/fcell.2022.851359. eCollection 2022.
7
A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol.一项多中心单臂客观性能标准试验,以确定高频不可逆电穿孔作为局限性前列腺癌主要治疗方法的疗效和安全性:一项研究方案。
Front Oncol. 2021 Nov 10;11:760003. doi: 10.3389/fonc.2021.760003. eCollection 2021.
8
Anaesthesia in PROstate Biopsy Pain Obstruction Study: A Study Protocol for a Multicentre Randomised Controlled Study Evaluating the Efficacy of Perineal Nerve Block in Controlling Pain in Patients Undergoing Transperineal Prostate Biopsy.前列腺活检疼痛梗阻研究中的麻醉:一项多中心随机对照研究的研究方案,评估会阴神经阻滞在控制经会阴前列腺活检患者疼痛方面的疗效。
Front Surg. 2021 Oct 6;8:649822. doi: 10.3389/fsurg.2021.649822. eCollection 2021.
9
Affordable novel device (VY) for transperineal prostate biopsy: A trial on prostate mannequin.用于经会阴前列腺活检的经济型新型设备(VY):在前列腺模型上的试验
MethodsX. 2021 Jun 18;8:101417. doi: 10.1016/j.mex.2021.101417. eCollection 2021.
10
Study protocol for a single-centre non-inferior randomised controlled trial on a novel three-dimensional matrix positioning-based cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy for the detection rate of clinically significant prostate cancer in men without a prior biopsy.一项新型基于三维矩阵定位的认知融合靶向活检和基于软件融合靶向活检与先前活检的男性临床显著前列腺癌检测率的单中心非劣效随机对照试验研究方案。
BMJ Open. 2021 Feb 5;11(2):e041427. doi: 10.1136/bmjopen-2020-041427.
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
多参数 MRI 和 TRUS 活检在前列腺癌(PROMIS)中的诊断准确性:一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
4
Complications After Systematic, Random, and Image-guided Prostate Biopsy.系统、随机和图像引导前列腺活检后的并发症。
Eur Urol. 2017 Mar;71(3):353-365. doi: 10.1016/j.eururo.2016.08.004. Epub 2016 Aug 17.
5
Comparison between Ultrasound Guided Transperineal and Transrectal Prostate Biopsy: A Prospective, Randomized, and Controlled Trial.超声引导下经会阴与经直肠前列腺穿刺活检的比较:一项前瞻性、随机对照试验
Sci Rep. 2015 Nov 3;5:16089. doi: 10.1038/srep16089.
6
Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.在确定最终Gleason评分和临床风险类别方面,经会阴前列腺活检比经直肠活检更准确吗?一项对比分析。
BJU Int. 2015 Oct;116 Suppl 3:26-30. doi: 10.1111/bju.13165. Epub 2015 Aug 11.
7
Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.对前列腺前尖区进行采样可提高经直肠重复饱和活检时癌症的检出率及分级。
BJU Int. 2016 Apr;117(4):592-7. doi: 10.1111/bju.13108. Epub 2015 May 14.
8
Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?脓毒症和“超级细菌”:我们应该赞成经会阴途径而非经直肠途径进行前列腺活检吗?
BJU Int. 2014 Sep;114(3):384-8. doi: 10.1111/bju.12536. Epub 2014 Feb 19.
9
Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy.模板前列腺图谱活检中的前列腺癌肿瘤特征:对焦化治疗的影响。
Eur Urol. 2014 Jul;66(1):12-9. doi: 10.1016/j.eururo.2013.09.045. Epub 2013 Oct 6.
10
High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.经会阴超声引导模板饱和活检术可显著提高前区前列腺肿瘤的检出率。
BJU Int. 2012 Oct;110(7):993-7. doi: 10.1111/j.1464-410X.2012.10972.x. Epub 2012 Mar 6.